Evidence map›Paper›PMID 36817058›Full record

ArticleOncology letters2023

Pathological tumor volume as a simple quantitative predictive factor of survival in oral squamous cell carcinoma.

Ivana Mijatov, Aleksandar Kiralj, Miroslav P Ilić, Nada Vučković, Aleksandar Spasić, Jelena Nikolić, Ana Tadić, Saša Mijatov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ivana MijatovFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Aleksandar KiraljFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Miroslav P IlićFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Nada VučkovićFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Aleksandar SpasićFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Jelena NikolićFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Ana TadićFaculty of Medicine, University of Novi Sad, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.
Saša MijatovClinic for Maxillofacial Surgery, University Clinical Center of Vojvodina, Novi Sad, Autonomous Province of Vojvodina 21000, Republic of Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is the eighth most common type of cancer in the world. Knowledge of prognostic factors of survival in OSCC is key. Several clinical and pathological prognostic factors have been investigated to develop a prognostic model of survival for patients with oral cancer. The present study focused on the association between pathological tumor volume (PTV) and overall survival time in patients with OSCC, regardless of cervical nodal status. The present study was a prospective study and covered 65 consecutive patients who received surgical treatment for oral cancer. The PTV was calculated according to dimensions of the postoperative specimen. Other pathological parameters as perineural and perivascular tumor spreading and extra-nodular propagation were also determined. The data were analyzed using the IBM SPSS 25.0 software. Cox PH regression model was built to analyze association between the PTV and survival time. Survival time was defined as the period from surgery to a target event or last contact. The results of the present study showed that PTV >4.24 cm

Indexed as

oral squamous cell carcinomaprognosticsurvivaltumor-node-metastasistumor volume

Identifiers

PMID36817058
PMCPMC9932573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.